Skip to main navigation
Skip to search
Skip to main content
Ariel University Home
Help & FAQ
Link opens in a new tab
English
עברית
العربية
Search content at Ariel University
Home
Profiles
Research units
Equipment
Research output
Prizes
Activities
Press/Media
Fusobacterium necrophorum as an Emerging Pathogen of Acute Mastoiditis
Miri Gelbart
, Efraim Bilavsky
, Gabriel Chodick
, Eyal Raveh
, Itzhak Levy
, Liat Ashkenazi-Hoffnung
Research output
:
Contribution to journal
›
Article
›
peer-review
31
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Fusobacterium necrophorum as an Emerging Pathogen of Acute Mastoiditis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Mastoiditis
100%
Fusobacterium Necrophorum
100%
Emerging Pathogens
100%
F. Necrophorum
100%
Clinical High Risk
50%
Mastitis
50%
Predictive Model
33%
Laboratory Characteristics
33%
Increased Incidence
16%
Clinical Features
16%
Clinical Characteristics
16%
Antibiotic Treatment
16%
Protein Value
16%
Surgical Intervention
16%
Electronic Health Records
16%
Clinical Laboratory
16%
Stepwise Logistic Regression
16%
C-reactive Protein
16%
Spring Season
16%
Prognostic Features
16%
Winter-spring
16%
Crude Incidence
16%
Anaerobic Coverage
16%
Anaerobic Culture
16%
Independent Risk Factors
16%
Tertiary Medical Center
16%
Area under the Receiver Operating Characteristic (AUROC)
16%
Clinical Prognostic
16%
Medicine and Dentistry
Mastoiditis
100%
Emerging Pathogen
100%
Fusobacterium necrophorum
100%
Infection
33%
Clinician
16%
Logistic Regression Analysis
16%
C Reactive Protein
16%
Antibiotic Therapy
16%
Electronic Patient Record
16%
Immunology and Microbiology
Mastoiditis
100%
Emerging Pathogen
100%
Fusobacterium necrophorum
100%
Infectious Disease
33%
Infection
33%
C-Reactive Protein
16%
Electronic Medical Record
16%
Antimicrobial Agent
16%
Nursing and Health Professions
Mastoiditis
100%
Infection
33%
Predictive Model
33%
Logistic Regression Analysis
16%
Antibiotic Therapy
16%
Electronic Medical Record
16%
Receiver Operating Characteristic
16%
C Reactive Protein
16%
Clinical Laboratory
16%